Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with established or probable Parkinson's disease, based on recognised diagnostic criteria
- People who experience involuntary movements (such as wriggling or writhing) at the point when their levodopa medication is working at its strongest (known as peak-of-dose dyskinesia)
- People whose Parkinson's medications have remained unchanged for at least four weeks
- People who are willing and able to give signed consent to participate
Who may not be able to join:
- People who have a psychiatric disorder
- People who are currently taking antipsychotic medication, Donepezil, or certain nerve-calming medications such as pregabalin or gabapentin
- People who regularly use benzodiazepines or opioid medications more than once per week
- People who have a history of a neurological condition other than Parkinson's disease
- People who have a personal history of epilepsy or any condition that may increase the risk of seizures triggered by a brain stimulation technique called TMS
- People who have close relatives with epilepsy or conditions that may increase the risk of seizures triggered by TMS
- People who have any medical reason they cannot have an MRI scan
- Female participants of childbearing age who are pregnant, or who are not willing to use contraception during the trial
- People who do not wish to be informed about any new or incidental health-related findings that may arise during their participation in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hartwig R. Siebner, Prof., Head of Research, Prof, DMSc
Phone: +45 38621184
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Unified Dyskinesia Rating Scale (UDysRS); Dyskinesia onset time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.